ArticleOncotarget2016

MiR-422a promotes loco-regional recurrence by targeting NT5E/CD73 in head and neck squamous cell carcinoma.

Nathalie Bonnin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.